PLX - Protalix Biotherapeutics - Stock Forecast

Healthcare - Sector
Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

PLX is currently covered by 1 analysts

Protalix Biotherapeutics's activity chart (see below) currently has 6 price targets and 8 ratings on display. The stock rating distribution of PLX is 100% BUY.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 33.33% with an average time for these price targets to be met of 210.33 days.

Highest price target for PLX is $2, Lowest price target is $2.

Most recent stock forecast was given by RAGHURAM SELVARAJU from HC WAINWRIGHT on 19-Mar-2026. First documented stock forecast 09-Nov-2012.

Best performing analysts who are covering PLX - Protalix Biotherapeutics:

Peter Welford Raghuram Selvaraju

Currently out of the existing stock ratings of PLX, 2 are a BUY (100%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Show more analysts

Please expand the browser size to see the chart

What is PLX (Protalix Biotherapeutics) average time for price targets to be met?

On average it took 210.33 days on average for the stock forecasts to be realized with a an average price target met ratio 33.33

Which analyst has the current highest performing score on PLX (Protalix Biotherapeutics) with a proven track record?

PETER WELFORD

Which analyst has the most public recommendations on PLX (Protalix Biotherapeutics)?

Peter Welford has 14 price targets and 9 ratings on PLX

Which analyst is the currently most bullish on PLX (Protalix Biotherapeutics)?

Raghuram Selvaraju with highest potential upside - $0

Which analyst is the currently most reserved on PLX (Protalix Biotherapeutics)?

Peter Welford with lowest potential downside - -$0.2

To continue looking at which analysts cover the stock please register to the basic or advanced membership

To continue looking at analysts data please register to the advanced membership

What is AnaChart?